Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
Posted On Friday, April 25, 2025
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
Posted On Friday, April 25, 2025
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Posted On Friday, April 25, 2025
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets
Posted On Friday, April 25, 2025
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Posted On Friday, April 25, 2025
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
Posted On Friday, April 25, 2025
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
Posted On Friday, April 25, 2025
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
Posted On Friday, April 25, 2025
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders
Posted On Friday, April 25, 2025
Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May
Posted On Thursday, April 24, 2025
Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Posted On Thursday, April 24, 2025
NurExone to Showcase Breakthrough in Facial Nerve Regeneration at ISEV 2025
Posted On Thursday, April 24, 2025
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
Posted On Thursday, April 24, 2025
FluidForm Bio™ Announces Advance in Bioprinted Tissue Therapies with Landmark Publication in Science Advances
Posted On Thursday, April 24, 2025
Seer to Report First Quarter 2025 Financial Results on May 13, 2025
Posted On Thursday, April 24, 2025
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
Posted On Thursday, April 24, 2025
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
Posted On Thursday, April 24, 2025
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
Posted On Thursday, April 24, 2025
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
Posted On Thursday, April 24, 2025
Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury
Posted On Thursday, April 24, 2025
Aemetis India Begins Biodiesel Shipments to Oil Marketing Companies under $31 Million Allocation For the Next Three Months
Posted On Thursday, April 24, 2025
Alkeus Pharmaceuticals Announces Presentations of Gildeuretinol Data During the Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
Posted On Thursday, April 24, 2025
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”
Posted On Thursday, April 24, 2025
Inmagene Reports Topline Results from Phase 2a Study of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-life, in Patients with Alopecia Areata
Posted On Thursday, April 24, 2025
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
Posted On Thursday, April 24, 2025

Print